118 related articles for article (PubMed ID: 21487220)
1. Impact of a combined intravenous/intra-arterial approach in octogenarians.
Mazighi M; Labreuche J; Meseguer E; Serfaty JM; Laissy JP; Lavallée PC; Cabrejo L; Guidoux C; Lapergue B; Klein IF; Olivot JM; Abboud H; Simon O; Schouman-Claeys E; Amarenco P
Cerebrovasc Dis; 2011; 31(6):559-65. PubMed ID: 21487220
[TBL] [Abstract][Full Text] [Related]
2. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
Jahan R; Vinuela F
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
[TBL] [Abstract][Full Text] [Related]
5. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
[TBL] [Abstract][Full Text] [Related]
6. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
Samaniego EA; Linfante I; Dabus G
Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
Shobha N; Buchan AM; Hill MD;
Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
[TBL] [Abstract][Full Text] [Related]
9. Influence of gender on outcomes after intra-arterial thrombolysis for acute ischemic stroke.
Shah SH; Liebeskind DS; Saver JL; Starkman S; Vinuela F; Duckwiler G; Jahan R; Kim D; Sanossian N; Vespa P; Ovbiagele B
Neurology; 2006 Jun; 66(11):1745-6. PubMed ID: 16769954
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial thrombolysis for acute ischemic stroke in octogenarians.
Mono ML; Romagna L; Jung S; Arnold M; Galimanis A; Fischer U; Kohler A; Ballinari P; Brekenfeld C; Gralla J; Schroth G; Mattle HP; Nedeltchev K
Cerebrovasc Dis; 2012; 33(2):116-22. PubMed ID: 22179504
[TBL] [Abstract][Full Text] [Related]
11. Rapid neurological recovery after intravenous tissue plasminogen activator in stroke: prognostic factors and outcome.
Machumpurath B; Davis SM; Yan B
Cerebrovasc Dis; 2011; 31(3):278-83. PubMed ID: 21178353
[TBL] [Abstract][Full Text] [Related]
12. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.
Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N;
Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study.
Mazighi M; Serfaty JM; Labreuche J; Laissy JP; Meseguer E; Lavallée PC; Cabrejo L; Slaoui T; Guidoux C; Lapergue B; Klein IF; Olivot JM; Abboud H; Simon O; Niclot P; Nifle C; Touboul PJ; Raphaeli G; Gohin C; Claeys ES; Amarenco P;
Lancet Neurol; 2009 Sep; 8(9):802-9. PubMed ID: 19647488
[TBL] [Abstract][Full Text] [Related]
14. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
Zhang B; Sun XJ; Ju CH
Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis.
Strbian D; Sairanen T; Rantanen K; Piironen K; Atula S; Tatlisumak T; Soinne L;
Cerebrovasc Dis; 2011; 31(1):37-42. PubMed ID: 20980752
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke.
Kappelle LJ; de Borst GJ
Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971
[No Abstract] [Full Text] [Related]
17. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
[TBL] [Abstract][Full Text] [Related]
18. Advances in thrombolytics for treatment of acute ischemic stroke.
Kirmani JF; Alkawi A; Panezai S; Gizzi M
Neurology; 2012 Sep; 79(13 Suppl 1):S119-25. PubMed ID: 23008386
[TBL] [Abstract][Full Text] [Related]
19. Randomised trials of endovascular treatment of stroke are needed.
Schott AM
Lancet Neurol; 2010 Jan; 9(1):30-1. PubMed ID: 20083032
[No Abstract] [Full Text] [Related]
20. Effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in older adults.
Dirks M; Koudstaal PJ; Dippel DW; Niessen LW; van Wijngaarden JD; Franke CL; van Oostenbrugge RJ
J Am Geriatr Soc; 2011 Nov; 59(11):2169-71. PubMed ID: 22098036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
